Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
LEXICON PHARMACEUTICALS, INC. (LXRX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
16 Nov 2023
COATS LONNEL
Chief Executive Officer, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
914,359
+10%
90,000
$1.05
$94,797.00
BUY
10 Nov 2023
COATS LONNEL
Chief Executive Officer, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
824,359
+1%
10,000
$1.01
$10,100.00
BUY
14 Sep 2023
WADE JEFFREY L
President and CFO, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
264,341
+3%
10,000
$1.38
$13,800.00
BUY
4 Aug 2023
McDermott Wendy
VP, Human Resources, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
28,478
+26%
6,000
$1.84
$11,040.00
BUY
29 Jun 2023
COATS LONNEL
Chief Executive Officer, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
814,359
+1%
10,000
$2.16
$21,600.00
BUY
23 Jun 2023
COATS LONNEL
Chief Executive Officer, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
804,359
+2%
20,000
$2.34
$46,742.00
BUY
23 Jun 2023
McDermott Wendy
VP, Human Resources, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
22,478
+80%
10,000
$2.43
$24,300.00
BUY
22 Jun 2023
COATS LONNEL
Chief Executive Officer, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
784,359
+5%
40,000
$2.31
$92,400.00
BUY
20 Jun 2023
WADE JEFFREY L
President and CFO, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
252,341
+4%
12,000
$2.33
$28,000.00
BUY
5 Jun 2023
Artal International S.C.A.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
78,634,380
+54%
27,775,050
$2.60
$72,215,130.00
SELL
15 Mar 2021
Tessmer James F
VP, Finance & Accounting, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
71,766
-24%
22,912
$6.92
$158,439.72
BUY
16 Dec 2020
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
32,259,460
+51%
10,937,500
$3.20
$35,000,000.00
BUY
16 Dec 2020
Artal International S.C.A.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
32,259,460
+51%
10,937,500
$3.20
$35,000,000.00
BUY
18 Sep 2019
COATS LONNEL
President and CEO, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
227,539
+28%
50,000
$3.10
$155,000.00
BUY
18 Sep 2019
Santini Alexander A
EVP and CCO, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
16,661
+37%
4,500
$3.36
$15,115.00
BUY
17 Sep 2019
COATS LONNEL
President and CEO, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
127,639
+64%
50,000
$3.13
$156,403.06
BUY
16 Sep 2019
SOBECKI CHRISTOPHER J
Director
LEXICON PHARMACEUTICALS, INC.
(LXRX)
112,493
+28%
25,000
$2.55
$63,717.59
BUY
13 Sep 2019
SOBECKI CHRISTOPHER J
Director
LEXICON PHARMACEUTICALS, INC.
(LXRX)
13,645
+115%
99,249
$2.41
$238,750.10
BUY
13 Sep 2019
DEBBANE RAYMOND
Director
LEXICON PHARMACEUTICALS, INC.
(LXRX)
223,634
+85%
103,042
$2.69
$277,591.22
BUY
13 Sep 2019
DEBBANE RAYMOND
Director
LEXICON PHARMACEUTICALS, INC.
(LXRX)
13,102
+107%
197,473
$2.40
$474,759.80
BUY
16 Aug 2019
COATS LONNEL
President and CEO, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
127,539
+45%
40,000
$1.35
$54,028.72
BUY
2 Aug 2019
Tessmer James F
VP, Finance & Accounting, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
43,368
+29%
10,000
$1.14
$11,400.00
BUY
2 Aug 2019
BARKER SAM L
Director
LEXICON PHARMACEUTICALS, INC.
(LXRX)
40,187
+148%
24,000
$1.18
$28,200.00
BUY
27 Jun 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
3,516,214
+5%
182,838
$12.51
$2,287,376.80
BUY
22 Jun 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
3,333,376
+8%
253,725
$12.99
$3,295,173.20
BUY
19 Jun 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
3,079,651
+2%
72,973
$13.29
$970,045.20
BUY
14 Jun 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
3,006,678
+1%
45,784
$12.98
$594,398.94
BUY
8 Jun 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
2,960,894
+8%
235,396
$12.80
$3,014,123.00
SELL
8 Jun 2018
Tessmer James F
VP, Finance & Accounting, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
25,643
-28%
10,000
$12.91
$129,076.01
BUY
5 Jun 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
2,725,498
+13%
325,639
$12.58
$4,095,065.00
BUY
25 May 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
2,399,859
+20%
416,481
$12.01
$5,002,666.50
BUY
25 May 2018
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
1,983,378
+27%
433,378
$9.94
$4,306,418.00
BUY
23 May 2018
Santini Alexander A
EVP and CCO, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
5,297
+16%
745
$9.78
$7,286.10
BUY
15 Nov 2017
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
1,550,000
+13%
180,727
$10.11
$1,826,895.90
BUY
15 Nov 2017
COATS LONNEL
President and CEO, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
42,985
+30%
10,000
$9.91
$99,100.00
BUY
14 Nov 2017
WADE JEFFREY L
EVP, Corp Adm Affairs and CFO, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
50,597
+4%
2,000
$9.48
$18,961.80
BUY
10 Nov 2017
Invus Public Equities, L.P.
Director, 10% Owner
LEXICON PHARMACEUTICALS, INC.
(LXRX)
1,369,273
+72%
575,946
$9.64
$5,554,165.50
BUY
15 Sep 2017
COATS LONNEL
President and CEO, Director, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
3,285
+112%
30,000
$12.54
$376,336.72
BUY
15 Sep 2017
BARKER SAM L
Director
LEXICON PHARMACEUTICALS, INC.
(LXRX)
25,623
+4%
1,000
$12.50
$12,500.00
SELL
6 Jun 2016
Tessmer James F
VP, Finance & Accounting, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
15,946
-8%
1,500
$15.00
$22,500.00
SELL
23 May 2016
Tessmer James F
VP, Finance & Accounting, Officer
LEXICON PHARMACEUTICALS, INC.
(LXRX)
15,946
-27%
6,000
$13.00
$78,000.00
Home